Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001924113 | SCV002199409 | uncertain significance | Muscle AMP deaminase deficiency | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 695 of the AMPD1 protein (p.Met695Ile). This variant is present in population databases (rs115092288, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with AMPD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1424886). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002560474 | SCV003568470 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.2085G>A (p.M695I) alteration is located in exon 15 (coding exon 15) of the AMPD1 gene. This alteration results from a G to A substitution at nucleotide position 2085, causing the methionine (M) at amino acid position 695 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001924113 | SCV003826233 | uncertain significance | Muscle AMP deaminase deficiency | 2019-06-27 | criteria provided, single submitter | clinical testing |